Around.: Difference between revisions
Eleanor61F (talk | contribs) mNo edit summary |
mNo edit summary |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
Panakès | Panakès Partners is a Financial backing firm, based in Milan, which buys the most ambitious business and groups, establishing cutting edge technologies and products, in the field of life sciences, intending to enhance the lives of people all over the world.<br><br>Established in 2010 by Dr. Ross 'Neill, CEO, Neuromod Devices is a clinical innovation company that is experts in the design and advancement of neuromodulation technologies to deal with the scientific demands of underserved client populaces who live with incapacitating and persistent problems.<br><br>The United States is a big market, 40 per cent of the worldwide hearing-aid market, and [https://www.protopage.com/odwaceojwe Bookmarks] 50 million Americans have tinnitus," said Dr 'Neill, the firm's owner, noting that the United States division of support's department of experienced affairs is the largest purchaser of listening device globally, buying regarding 800,000 a year to service 1.5 million experts with hearing loss. <br><br>The first of these tests, TENT-A1, stands for among the largest and longest followed-up medical trials ever carried out in the tinnitus area and was the cover tale for the clinical journal Scientific research Translational Medication in October 2020. | ||
Latest revision as of 20:13, 15 June 2024
Panakès Partners is a Financial backing firm, based in Milan, which buys the most ambitious business and groups, establishing cutting edge technologies and products, in the field of life sciences, intending to enhance the lives of people all over the world.
Established in 2010 by Dr. Ross 'Neill, CEO, Neuromod Devices is a clinical innovation company that is experts in the design and advancement of neuromodulation technologies to deal with the scientific demands of underserved client populaces who live with incapacitating and persistent problems.
The United States is a big market, 40 per cent of the worldwide hearing-aid market, and Bookmarks 50 million Americans have tinnitus," said Dr 'Neill, the firm's owner, noting that the United States division of support's department of experienced affairs is the largest purchaser of listening device globally, buying regarding 800,000 a year to service 1.5 million experts with hearing loss.
The first of these tests, TENT-A1, stands for among the largest and longest followed-up medical trials ever carried out in the tinnitus area and was the cover tale for the clinical journal Scientific research Translational Medication in October 2020.